Amyris, Inc. (AMRS) Strengthens Stance in Global Nutraceuticals Market with Collaboration, Partner Funding of $30M
Amyris (NASDAQ: AMRS), an industrial bioscience company, this morning reported that it has expanded its previously announced partnership with a global nutraceuticals market leader in a deal that extends Amyris’ expected revenue and includes the addition of a new nutraceutical target, a credit line of up to $25 million with a five-year maturity, and an option for a $5-million strategic investment from one of the world’s leading nutraceuticals manufacturers. As part of the initial agreement, Amyris has already started large shipments of farnesene; the partner is nearing completion of a dedicated manufacturing facility to convert Amyris’ farnesene and expand volume…







